Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Creatinolfosfate [INN]
RN: 6903-79-3
UNII: 5O564RN1QD
InChIKey: FOIPWTMKYXWFGC-UHFFFAOYSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C4-H12-N3-O4-P

Molecular Weight

  • 197.13
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Creatinol phosphate
  • Creatinolfosfate [INN]

Synonyms

  • 1-(2-Hydroxyethyl)-1-methylguanidine dihydrogen phosphate (ester)
  • 2-(1-Methylguanidino)ethyl dihydrogenphosphat
  • Aplodan
  • BRN 1911880
  • Creatinol O-phosphate
  • Creatinol phosphate
  • Creatinol-O-phosphate
  • Creatinolfosfate
  • Creatinolfosfato
  • Creatinolfosfato [INN-Spanish]
  • Creatinolfosfatum
  • Creatinolfosfatum [INN-Latin]
  • Creatinolo O-fosfato
  • Creatinolo O-fosfato [Italian]
  • EINECS 230-011-8
  • Gipron
  • N-Methyl-N-(2-(phosphonooxy)ethyl)guanidine
  • N-Methyl-N-(beta-hydroxyaethyl)guanidine-O-phosphat
  • N-Methyl-N-(beta-hydroxyaethyl)guanidine-O-phosphat [German]
  • N-Methyl-N-(beta-hydroxyethyl)guanidine O-phosphate
  • Nergize
  • UNII-5O564RN1QD

Systematic Names

  • 1-(2-Hydroxyethyl)-1-methylguanidine dihydrogen phosphate (ester)
  • Creatinolfosfate
  • Guanidine, 1-(2-hydroxyethyl)-1-methyl-, dihydrogen phosphate (ester)
  • Guanidine, N-methyl-N-(2-(phosphonooxy)ethyl)-, (9CI)

Registry Numbers

CAS Registry Number

  • 6903-79-3

FDA UNII

  • 5O564RN1QD

Other Registry Numbers

  • 860497-46-7
  • 874098-09-6

System Generated Number

  • 0006903793

Structure Descriptors

InChI

1S/C4H12N3O4P/c1-7(4(5)6)2-3-11-12(8,9)10/h2-3H2,1H3,(H3,5,6)(H2,8,9,10)

InChIKey

FOIPWTMKYXWFGC-UHFFFAOYSA-N

Smiles

P(OCCN(C(N)=N)C)(O)(O)=O

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
guinea pig LD50 intraperitoneal 3200mg/kg (3200mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979.
guinea pig LD50 intravenous 1500mg/kg (1500mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE

BEHAVIORAL: ATAXIA
Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979.
guinea pig LD50 oral > 5gm/kg (5000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979.
mouse LD50 intraperitoneal 3gm/kg (3000mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979.
mouse LD50 intravenous 1200mg/kg (1200mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA

PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979.
mouse LD50 oral > 5gm/kg (5000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979.
rat LD50 intraperitoneal 4800mg/kg (4800mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979.
rat LD50 intravenous 1300mg/kg (1300mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA

PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979.
rat LD50 oral > 5gm/kg (5000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 29, Pg. 1449, 1979.